Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study.

Wikén M, Hallén B, Kullenberg T, Koskinen LO.

Clin Rheumatol. 2018 Dec;37(12):3381-3386. doi: 10.1007/s10067-018-4196-x. Epub 2018 Jul 7.

PMID:
29982913
2.

Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis.

Martini E, Wikén M, Cheuk S, Gallais Sérézal I, Baharom F, Ståhle M, Smed-Sörensen A, Eidsmo L.

J Invest Dermatol. 2017 Apr;137(4):865-873. doi: 10.1016/j.jid.2016.11.033. Epub 2016 Dec 21.

3.

Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis.

Cheuk S, Wikén M, Blomqvist L, Nylén S, Talme T, Ståhle M, Eidsmo L.

J Immunol. 2014 Apr 1;192(7):3111-20. doi: 10.4049/jimmunol.1302313. Epub 2014 Mar 7.

4.

Antigen-specific multifunctional T-cells in sarcoidosis patients with Lofgren's syndrome.

Wikén M, Ostadkarampour M, Eklund A, Willett M, Chen E, Moller D, Grunewald J, Wahlström J.

Eur Respir J. 2012 Jul;40(1):110-21. doi: 10.1183/09031936.00166110. Epub 2011 Dec 19.

5.

Multiparameter phenotyping of T-cell subsets in distinct subgroups of patients with pulmonary sarcoidosis.

Wikén M, Grunewald J, Eklund A, Wahlström J.

J Intern Med. 2012 Jan;271(1):90-103. doi: 10.1111/j.1365-2796.2011.02414.x. Epub 2011 Jul 13.

6.

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use.

Frandsen TP, Naested H, Rasmussen SK, Hauptig P, Wiberg FC, Rasmussen LK, Jensen AM, Persson P, Wikén M, Engström A, Jiang Y, Thorpe SJ, Förberg C, Tolstrup AB.

Biotechnol Bioeng. 2011 Sep;108(9):2171-81. doi: 10.1002/bit.23166. Epub 2011 Apr 25.

PMID:
21495017
7.

No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.

Wikén M, Idali F, Al Hayja MA, Grunewald J, Eklund A, Wahlström J.

Respir Res. 2010 Sep 2;11:121. doi: 10.1186/1465-9921-11-121.

8.

T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Chen ES, Wahlström J, Song Z, Willett MH, Wikén M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, Grunewald J, Moller DR.

J Immunol. 2008 Dec 15;181(12):8784-96.

9.

Increased levels of nerve growth factor in the airways of patients with sarcoidosis.

Dagnell C, Grunewald J, Idali F, Wikén M, Kemi C, Sköld CM, Planck A, Newman LS, Eklund A, Olgart Höglund C.

J Intern Med. 2008 Nov;264(5):463-71. doi: 10.1111/j.1365-2796.2008.01988.x. Epub 2008 Sep 6.

10.

Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis.

Wikén M, Grunewald J, Eklund A, Wahlström J.

J Clin Immunol. 2009 Jan;29(1):78-89. doi: 10.1007/s10875-008-9225-0. Epub 2008 Sep 5.

PMID:
18773284
11.

Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis.

Idali F, Wikén M, Wahlström J, Mellstedt H, Eklund A, Rabbani H, Grunewald J.

Eur Respir J. 2006 Mar;27(3):451-9.

12.
14.

Enhancement of human B-cell proliferation by a monoclonal antibody to CD43.

Wikén M, Björck P, Axelsson B, Perlmann P.

Scand J Immunol. 1989 Mar;29(3):363-70.

PMID:
2785707
15.

Studies on the role of CD43 in human B-cell activation and differentiation.

Wikén M, Björck P, Axelsson B, Perlmann P.

Scand J Immunol. 1989 Mar;29(3):353-61.

PMID:
2785706
16.

Induction of CD43 expression during activation and terminal differentiation of human B cells.

Wikén M, Björck P, Axelsson B, Perlmann P.

Scand J Immunol. 1988 Oct;28(4):457-64.

PMID:
3264083
17.

Functional characterization of human B cells carrying the lymphocyte large sialoglycoprotein gp150.

Wikén M, Robertsson ES, Axelsson B, Perlmann P.

Scand J Immunol. 1987 Nov;26(5):477-85.

PMID:
3500501
18.
19.

The use of supernatants from neuraminidase and galactose oxidase (NAGO)-treated lymphocytes as a source of T cell growth factor.

Berzins T, Wikén M, Hellström U, Perlmann P.

J Immunol Methods. 1983 Oct 28;63(3):309-19.

PMID:
6605390

Supplemental Content

Support Center